Acusphere, Inc. is a pharmaceutical company, which engages in the development of drugs and formulations of existing drugs using proprietary micro particle technology. The company is headquartered in Lexington, Massachusetts. The company went IPO on 2003-10-08. The firm is focused on the development of Imagify, which contains Perflubutane Polymer Microspheres for injectable suspension. The firm's product Imagify is a cardiovascular drug for the detection of coronary artery disease (CAD). Imagify injectable suspension consists of porous, synthetic polymer microspheres containing gas that are administered intravenously and act as tracers of blood flow or perfusion. The firm has submitted the Marketing Authorization Application (MAA) for its lead product candidate, Imagify lyophilisate for dispersion for injection with the European Medicines Agency (EMA) to support the regulatory review of Imagify in the European Union (EU).
Follow-Up Questions
Quel est le ratio P/E de Acusphere Inc (ACUS) ?
Le ratio P/E de Acusphere Inc est de 0
Qui est le CEO de Acusphere Inc ?
Mr. Mark Leuchtenberger est le President de Acusphere Inc, il a rejoint l'entreprise depuis 2013.
Quelle est la performance du prix de l'action ACUS ?
Le prix actuel de ACUS est de $0, il a decreased de 0% lors de la dernière journée de trading.
Quels sont les thèmes d'affaires principaux ou les industries de Acusphere Inc ?
Acusphere Inc appartient à l'industrie Pharmaceuticals et le secteur est Health Care
Quelle est la capitalisation boursière de Acusphere Inc ?
La capitalisation boursière actuelle de Acusphere Inc est de $0
